Ceppi Marco G, Rauch Marlene S, Spöndlin Julia, Gantenbein Andreas R, Meier Christoph R, Sándor Peter S
Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Neurorehabilitation and Research Department, ZURZACH Care, Bad Zurzach, Switzerland.
Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.
J Am Med Dir Assoc. 2023 Apr;24(4):519-525.e6. doi: 10.1016/j.jamda.2023.01.012. Epub 2023 Feb 21.
To investigate the association between a wide set of baseline characteristics (age, sex, rehabilitation discipline), functional scores [Functional Independence Measure (FIM), cumulative Illness Rating Scale (CIRS)], diseases, and administered drugs and incident delirium in rehabilitation inpatients and, furthermore, to assess clinical implications of developing delirium during rehabilitation.
Matched case-control study based on electronic health record data.
We studied rehabilitation stays of inpatients admitted between January 1, 2015, and December 31, 2018, to ZURZACH Care, Rehaklinik Bad Zurzach, an inpatient rehabilitation clinic in Switzerland.
We conducted unconditional logistic regression analyses to estimate adjusted odds ratios (AORs) with 95% CIs of exposures that were recorded in ≥5 cases and controls.
Among a total of 10,503 rehabilitation stays, we identified 125 validated cases. Older age, undergoing neurologic rehabilitation, a low FIM, and a high CIRS were associated with an increased risk of incident delirium. Being diagnosed with a bacterial infection (AOR 2.62, 95% CI 1.06-6.49), a disorder of fluid, electrolyte, or acid-base balance (AOR 2.76, 95% CI 1.19-6.38), Parkinson's disease (AOR 5.68, 95% CI 2.54-12.68), and administration of antipsychotic drugs (AOR 8.06, 95% CI 4.26-15.22), antiparkinson drugs (AOR 2.86, 95% CI 1.42-5.77), drugs for constipation (AOR 2.11, 95% CI 1.25-3.58), heparins (AOR 2.04, 95% CI 1.29-3.24), or antidepressant drugs (AOR 1.88, 95% CI 1.14-3.10) during rehabilitation, or an increased anticholinergic burden (ACB ≥ 3) (AOR 2.59, 95% CI 1.41-4.73) were also associated with an increased risk of incident delirium.
We identified a set of factors associated with an increased risk of incident delirium during inpatient rehabilitation. Our findings contribute to detect patients at risk of delirium during inpatient rehabilitation.
研究一系列基线特征(年龄、性别、康复学科)、功能评分[功能独立性测量量表(FIM)、累积疾病评定量表(CIRS)]、疾病及使用药物与康复住院患者谵妄发生之间的关联,并进一步评估康复期间发生谵妄的临床意义。
基于电子健康记录数据的匹配病例对照研究。
我们研究了2015年1月1日至2018年12月31日期间入住瑞士巴德措尔扎赫康复诊所ZURZACH Care的住院患者的康复情况。
我们进行了无条件逻辑回归分析,以估计暴露因素的调整比值比(AOR)及95%置信区间,这些暴露因素在≥5例病例和对照中被记录。
在总共10503次康复住院中,我们确定了125例确诊病例。年龄较大、接受神经康复治疗、FIM评分低及CIRS评分高与谵妄发生风险增加相关。康复期间被诊断为细菌感染(AOR 2.62,95%置信区间1.06 - 6.49)、液体、电解质或酸碱平衡紊乱(AOR 2.76,95%置信区间1.19 - 6.38)、帕金森病(AOR 5.68,95%置信区间2.54 - 12.68),以及使用抗精神病药物(AOR 8.06,95%置信区间4.26 - 15.22)、抗帕金森药物(AOR 2.86,95%置信区间1.42 - 5.77)、治疗便秘的药物(AOR 2.11,95%置信区间1.25 - 3.58)、肝素(AOR 2.04,95%置信区间1.29 - 3.24)或抗抑郁药物(AOR 1.88,95%置信区间1.14 - 3.10),或抗胆碱能负担增加(ACB≥3)(AOR 2.59,95%置信区间1.41 - 4.73)也与谵妄发生风险增加相关。
我们确定了一组与住院康复期间谵妄发生风险增加相关的因素。我们的研究结果有助于在住院康复期间识别有谵妄风险的患者。